Phase 1a/1b study of the safety, pharmacokinetics, and antitumor activity of ziftomenib in combination with imatinib in patients with advanced gastrointestinal stromal tumors (GIST) after imatinib failure.
Mark Agulnik, Jason K. Sicklick, S. Patel, Mrinal M. Gounder et autres
0 citationsJournal of Clinical Oncology